Parabiago, Italy

Marinella Caruso

This inventor holds 2 USPTO granted patents. Top assignee: Pharmacia & Upjohn. Active years: 1997-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marinella Caruso. Retrieved from https://idiyas.com/inventor/marinella-caruso

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 19(Granted Patents)


Location History:

  • Milan, IT (1997)
  • Parabiago, IT (2003)

Company Filing History:


Years Active: 1997-2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Marinella Caruso: Innovator in Microbial Biotechnology

Introduction

Marinella Caruso is a notable inventor based in Parabiago, Italy. She has made significant contributions to the field of microbial biotechnology, particularly in the production of taxanes and the study of drug resistance.

Latest Patents

Marinella Caruso holds 2 patents. Her latest patents include "Paclitaxel production by actinomycetes," which focuses on microorganisms that produce taxanes, such as paclitaxel. This invention details the use of specific actinomycetes for taxane production and the isolation procedures for these microorganisms from plants. Another significant patent is "Isolation and characterisation of genes resistant to anthracycline," which addresses doxorubicin resistance in hosts through the use of recombinant vectors.

Career Highlights

Marinella Caruso is associated with Pharmacia & Upjohn, where she has been instrumental in advancing research in her field. Her work has implications for cancer treatment and microbial applications in pharmaceuticals.

Collaborations

Some of her notable coworkers include Umberto Breme and Nicoletta Crespi Perellino, who have collaborated with her on various research projects.

Conclusion

Marinella Caruso's innovative work in microbial biotechnology and her contributions to the understanding of drug resistance highlight her importance in the field. Her patents reflect her commitment to advancing scientific knowledge and improving therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…